Learn about cannabis for individuals living with Crohn's or colitis. Experts discuss the use of cannabis for intestinal disorders, gut inflammation, symptom management and what current research tells us about cannabis and IBD. Frequently asked questions are answered in this interactive webinar.
Dr. Keith Sharkey (Ph.D) is a Professor of Physiology and Pharmacology and Crohn's and Colitis Canada (CCC) Chair in IBD Research at the University of Calgary.
Dr. Yasmin Nasser (MD Ph.D. FRCPC) is a is a Clinical Assistant Professor in the Department of Medicine and a clinician-scientist in the Division of Gastroenterology and Hepatology at the University of Calgary. As a clinician-scientist, she is a member of the Gastrointestinal Research Group and a member of the Snyder Institute for chronic disease.
This education presentation is supported by Canopy Growth
Disclaimer: There is no scientific evidence that the use of medical marijuana in any form prevents IBD symptoms and Crohn's and Colitis Canada does not endorse the use of any cannabis product.